These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 79898)

  • 21. Kefzol (cefazolin sodium, Lilly).
    Bader J; McCain E
    Curr Ther Res Clin Exp; 1975 Jan; 17(1):117-22. PubMed ID: 806425
    [No Abstract]   [Full Text] [Related]  

  • 22. [Activity of cefazolin against Gram-negative bacteria].
    Dzierzanowska D; Niedźwiecka M; Jakubicz P; Borowski J
    Pol Tyg Lek; 1978 Dec; 33(52):1989-91. PubMed ID: 733630
    [No Abstract]   [Full Text] [Related]  

  • 23. Relationships between in vitro susceptibility and efficacy in experimental mouse infection-protection assay of cefazolin and cephalothin using Escherichia coli strains.
    Uri JV; Actor P; Phillips L; Guarini JR; Weisbach JA
    Chemotherapy; 1976; 22(5):313-8. PubMed ID: 780071
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Susceptibility to cefazolin, cefamandole and ceftazidime in Staphylococcus strains].
    Wiktorowicz-Belzyt E; Wojak I; Janicka G
    Med Dosw Mikrobiol; 1997; 49(1-2):35-43. PubMed ID: 9411070
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Structure-activity relationship of cephalosporins. II. Effect of oxygen-containing functional groups on the biological activity od cephalosporins--derivatives of 7-aminocephalosporanic acid].
    Grabarnik MS; Iakhkind MI; Znamenskiĭ IuV; Kocherezhko NA
    Antibiot Khimioter; 1991 Apr; 36(4):12-5. PubMed ID: 1909856
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Structure-activity relationship of cephalosporins. III. Effect of sulfur-containing functional groups on the biological activity of cephalosporins--derivatives of 7-aminocephalosporanic acid].
    Grabarnik MS; Iakhkind MI; Znamenskiĭ IuV; Kocherezhko NA
    Antibiot Khimioter; 1991 Apr; 36(4):15-7. PubMed ID: 1909857
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Activity of selected cephalosporin antibiotics against clinical strains of gram-negative bacteria].
    Dzierzanowska D; Kaźmirowska Z; Kołodziejczyk J; Lawicka K; Mészaros J
    Pol Tyg Lek; 1987 Dec; 42(49):1539-41. PubMed ID: 3131750
    [No Abstract]   [Full Text] [Related]  

  • 28. Effect of sulfur hexafluoride gas on antibacterial activity of antibiotics in vitro against agents causing endophthalmitis.
    Yanyali A; Cetin S; Talu H; Vahaboglu H
    Ophthalmologica; 2001; 215(6):439-43. PubMed ID: 11741112
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cefazedone: microbiological evaluation in comparison with cephalothin and cefazolin.
    Wahlig H; Dingeldein E; Mitsuhashi S; Kawabe H
    Arzneimittelforschung; 1979; 29(2a):369-78. PubMed ID: 582712
    [No Abstract]   [Full Text] [Related]  

  • 30. [In-vitro sensitivity of Klebsiella-Enterobacter strains against cefazolin (author's transl)].
    Krasemann C; Peckelsen C
    Dtsch Med Wochenschr; 1977 Jan; 102(3):87-90. PubMed ID: 832585
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activity of cephalosporin CXA-101 (FR264205) against Pseudomonas aeruginosa and Burkholderia cepacia group strains and isolates.
    Livermore DM; Mushtaq S; Ge Y; Warner M
    Int J Antimicrob Agents; 2009 Nov; 34(5):402-6. PubMed ID: 19428220
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Cefoperazone in infections caused by resistant agents, with special reference to Pseudomonas aeruginosa].
    Torres A; Vega J; Aguirre M; Alés JM
    Rev Clin Esp; 1982 Feb; 164(4):229-32. PubMed ID: 6211752
    [No Abstract]   [Full Text] [Related]  

  • 33. [Enzymatic stability in vivo of a new cephalosporin active against Pseudomonas aeruginosa: ceftazidime].
    Vittecoq D; Philippon A; Nevot P; Modai J
    Presse Med; 1984 Jun; 13(23):1462. PubMed ID: 6233605
    [No Abstract]   [Full Text] [Related]  

  • 34. Antimicrobial activity of ceftolozane/tazobactam tested against Pseudomonas aeruginosa and Enterobacteriaceae with various resistance patterns isolated in European hospitals (2011-12).
    Sader HS; Farrell DJ; Castanheira M; Flamm RK; Jones RN
    J Antimicrob Chemother; 2014 Oct; 69(10):2713-22. PubMed ID: 24917579
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activity of the new cephalosporin CXA-101 (FR264205) against Pseudomonas aeruginosa isolates from chronically-infected cystic fibrosis patients.
    Zamorano L; Juan C; Fernández-Olmos A; Ge Y; Cantón R; Oliver A
    Clin Microbiol Infect; 2010 Sep; 16(9):1482-7. PubMed ID: 20002107
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro and in vivo comparative evaluations of injectable cephalosporin derivatives and ampicillin.
    Gotô S; Kuwahara S
    Chemotherapy; 1976; 22(5):286-96. PubMed ID: 1047636
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antimicrobial Activity of Ceftolozane-Tazobactam Tested Against Enterobacteriaceae and Pseudomonas aeruginosa with Various Resistance Patterns Isolated in U.S. Hospitals (2013-2016) as Part of the Surveillance Program: Program to Assess Ceftolozane-Tazobactam Susceptibility.
    Shortridge D; Pfaller MA; Castanheira M; Flamm RK
    Microb Drug Resist; 2018 Jun; 24(5):563-577. PubMed ID: 29039729
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cefazolin.
    Griffith RS
    Adv Clin Pharmacol; 1974; 8():123-7. PubMed ID: 4468727
    [No Abstract]   [Full Text] [Related]  

  • 39. [Antipseudomonal activities of new cephem antibiotics].
    Ohkoshi M
    Hinyokika Kiyo; 1984 Apr; 30(4):437-48. PubMed ID: 6435413
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [In vivo-acquired resistance to cefsulodin by a strain of Pseudomonas aeruginosa].
    Jouvenot M; Michel-Briand Y; Dupont MJ; Cattin J
    Pathol Biol (Paris); 1984 May; 32(5):426-8. PubMed ID: 6429615
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.